Last reviewed · How we verify

NCT07197879: DynSit-Pain 2

Effect of Dynamic Sitting on Pain Development - Part 2

Recruiting now NA Last updated 29 September 2025
What this trial tests

NA trial testing Dynamic office chair (saddle chair with standard pendulum mechanism) in Lower Back Pain in 20 participants. Currently enrolling.

Timeline
12 May 2025
Primary endpoint
31 December 2026
31 March 2027

Quick facts

Lead sponsorUniversity of Applied Sciences for Health Professions Upper Austria
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeprevention
Enrollment20
Start date12 May 2025
Primary completion31 December 2026
Estimated completion31 March 2027
Sites1 location across Austria

Drugs / interventions tested

Conditions studied

Sponsor

University of Applied Sciences for Health Professions Upper Austria

Who can join

Adults 18 to 65, any sex, with Lower Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

As a follow-up project to the Dyn-Sit-Pain study, this research aims to investigate the overall health as well as the physical and mental well-being through dynamic office chairs. The development of an innovative dynamic office chair concept will be professionally and scientifically supported, and the developed prototypes will be examined within the framework of usability studies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lower Back Pain

Currently open trials in the same condition.

Other University of Applied Sciences for Health Professions Upper Austria trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07197879.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing